Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia
This study was registered prospectively on October 21, 2014 and assigned trial number NCT02269267 .
PubMed Central ID
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency